Search for Clinical Trial Results

Sponsored By

Biliary Tract Cancer - 162 Studies Found

Status Study
Completed Study Name: Second Line Therapy in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Date: 2012-02-03
Interventions:
  • Drug: capecitabine and mitomycin

Recruiting Study Name: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Condition: Biliary Tract Cancer
Date: 2017-05-05
Interventions: Drug: Apatinib Apatinib 500mg, po, qd, every 4 weeks.
Active, not recruiting Study Name: Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who Failed Gemcitabine-based Combination Chemotherapy
Condition: Biliary Tract Cancer
Date: 2015-10-16
Interventions: Drug: Lenvatinib Lenvatinib will be administered orally once daily in 28-day cycles. Participants will b
Withdrawn Study Name: Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
Condition: Biliary Tract Cancer
Date: 2016-03-23
Interventions: Drug: Irinotecan & Capecitabine Irinotecan will be administered at infusion room over 60 minutes. Ca
Completed Study Name: Vessel Resection and Reconstruction of Biliary Tract Cancers
Condition: Biliary Tract Cancer
Date: 2013-05-14
Completed Study Name: Case Series Study of Biliary Tract Cancer Patients in Japan
Condition: Biliary Tract Cancer
Date: 2011-01-03
Completed Study Name: A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
Condition: Biliary Tract Cancer
Date: 2006-06-19
Active, not recruiting Study Name: GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Date: 2014-06-28
Interventions:
  • Drug: Gemcitabine/Cisplatin Ge
Recruiting Study Name: MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Date: 2016-05-13
Interventions: Drug: MEK162+capecitabine In phase 1 part: capecitabine(mg/m2) will be given twice a day, 2 week on/1wee
Recruiting Study Name: A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
Condition: Unresectable Biliary Tract Cancer
Date: 2015-12-14
Interventions: Drug: nab-paclitaxel in combination with gemcitabine + cisplatin Patients with unresectable BTC will be
Next >>>